TNXP

12.45

0.80% -0.10

Handel nachbörslich: 12.42 -0.03 -0.24%

Tonix Pharmaceuticals Holding Corp (TNXP)

Überblick Nachrichten Preisverlauf Financials Warum fällt TNXP? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$12.55

Offen:

$12.89

24-Stunden-Volumen:

249.68K

Relative Volume:

0.48

Marktkapitalisierung:

$213.53M

Einnahmen:

$13.11M

Nettoeinkommen (Verlust:

$-124.02M

KGV:

-0.873

EPS:

-14.261

Netto-Cashflow:

$-107.25M

1W Leistung:

-1.66%

1M Leistung:

+26.01%

6M Leistung:

-12.88%

1J Leistung:

-67.22%

1-Tages-Spanne:

$12.25

$12.90

1-Wochen-Bereich:

$12.25

$13.16

52-Wochen-Spanne:

$9.40

$37.56

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Firmenname

Tonix Pharmaceuticals Holding Corp

Sektor

Healthcare (1033)

Branche

Biotechnology (582)

Telefon

212-980-9155

Adresse

200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NY

Mitarbeiter

142

Twitter

@TONIXPharma

Nächster Verdiensttermin

2026-08-10

Neueste SEC-Einreichungen

TNXP's Discussions on Twitter

Compare TNXP vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TNXP Tonix Pharmaceuticals Holding Corp	12.45	212.50M	13.11M	-124.02M	-107.25M	-14.26
VRTX Vertex Pharmaceuticals Inc	547.59	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	828.50	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,011.11	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.89	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.58	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-04-18	Eingeleitet	Noble Capital Markets	Outperform
2019-04-18	Hochstufung	ROTH Capital	Neutral → Buy
2017-08-18	Hochstufung	ROTH Capital	Neutral → Buy
2016-09-07	Herabstufung	ROTH Capital	Buy → Neutral
2016-02-17	Bestätigt	Oppenheimer	Outperform
2015-11-04	Eingeleitet	Cantor Fitzgerald	Buy
2015-06-12	Eingeleitet	Oppenheimer	Outperform
2015-02-17	Bestätigt	ROTH Capital	Buy
2014-09-29	Bestätigt	ROTH Capital	Buy

Alle ansehen

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

Aug 20, 2026

TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits

Aug 20, 2026

Aug 19, 2026

Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript - AOL.com

Aug 19, 2026

Aug 18, 2026

TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug - Stocktwits

Aug 18, 2026

Tonix (TNXP) Daily Snapshot: Finishes 0.16% Higher at $12.68 in Latest Trading; the $12.05 to $13.31 Range Remains in Focus under the Current SnapshotValue Area High - Vinanet

Aug 18, 2026

Why TNXP Stock Is Suddenly Back On Retail Radar - stocktwits.com

Aug 18, 2026

Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline - MarketBeat

Aug 18, 2026

Tonix Pharmaceuticals (TNXP) 10K Form and Latest SEC Filings 2026 - MarketBeat

Aug 18, 2026

Aug 17, 2026

Tonix Pharmaceuticals (TNXP) Holds Ground at $12.66 as Traders Eye $13.29 ResistanceTrend Reversal Picks - vinanet.vn

Aug 17, 2026

Aug 14, 2026

Tonix Pharmaceuticals Holding Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:TNXP) 2026-08-14 - Seeking Alpha

Aug 14, 2026

Sirenia Capital (TNXP) discloses 4.9% Tonix Pharmaceuticals stake including warrants - Stock Titan

Aug 14, 2026

Aug 13, 2026

AQR Capital discloses 5.54% ownership in Tonix Pharmaceuticals (TNXP) via Schedule 13G - Stock Titan

Aug 13, 2026

TNXP Q2 2026 Earnings: Better-Than-Expected Loss per Share, Shares Dip 3%Guidance Accuracy Score - Vinanet

Aug 13, 2026

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - simplywall.st

Aug 13, 2026

Aug 12, 2026

Tonix Pharmaceuticals Holding Corp.Common Stock (NQ: TNXP - FinancialContent

Aug 12, 2026